186
Participants
Start Date
June 19, 2018
Primary Completion Date
December 17, 2019
Study Completion Date
May 22, 2020
Botulinum toxin type A
Investigators will inject the reconstituted solution into foot muscles.
Placebo
Investigators will inject the reconstituted solution into foot muscles.
Harrisburg Foot and Ankle Center, INC, Harrisburg
Foot and Ankle Center, Bryn Mawr
The Chesapeake Research Group, Pasadena
Ankle and Foot Care Centers, Youngstown
Harrisonburg Foot and Ankle Clinic, Harrisonburg
1Foot 2Foot Centre for Foot and Ankle Care, PC, Suffolk
Martinsville Research Institute, Inc., Salem
Conquest Research, Orlando
LCC Medical Research Institute, Miami
Doctors Research Network, South Miami
Clinical Research, West Palm Beach
Weil Foot & Ankle Institute, Des Plaines
Rosalind Franklin Clinic, North Chicago
Podiatry 1st, Belleville
Foot and Ankle Center of Illinois, Springfield
Dr. Allen M. Jacobs and Associates, St Louis
Applied Research Center of Arkansas, Inc, Little Rock
NEA Baptist Clinic, Jonesboro
Medical Research International, Oklahoma City
Texas Gulf Coast Medical Group, Webster
Bio X Cell Research, San Antonio
Futuro Clinical Trials, LLC, McAllen
Center for Spine and Orthopedics, Thornton
Summit Foot & Ankle, Salt Lake City
Southwestern Academic Limb Salvage Alliance, Los Angeles
Foot and Ankle Clinic, Los Angeles
University Foot and Ankle Institute, Santa Monica
Limb Preservation Platform, Inc., Fresno
Center for Clinical Research Inc., Castro Valley
Lead Sponsor
Ipsen
INDUSTRY